115 related articles for article (PubMed ID: 12393709)
1. Lymphoproliferative defects in mice lacking the expression of neurofibromin: functional and biochemical consequences of Nf1 deficiency in T-cell development and function.
Ingram DA; Zhang L; McCarthy J; Wenning MJ; Fisher L; Yang FC; Clapp DW; Kapur R
Blood; 2002 Nov; 100(10):3656-62. PubMed ID: 12393709
[TBL] [Abstract][Full Text] [Related]
2. The Ras GTPase-activating protein neurofibromin 1 promotes the positive selection of thymocytes.
Oliver JA; Lapinski PE; Lubeck BA; Turner JS; Parada LF; Zhu Y; King PD
Mol Immunol; 2013 Oct; 55(3-4):292-302. PubMed ID: 23522726
[TBL] [Abstract][Full Text] [Related]
3. The neurofibromin GAP-related domain rescues endothelial but not neural crest development in Nf1 mice.
Ismat FA; Xu J; Lu MM; Epstein JA
J Clin Invest; 2006 Sep; 116(9):2378-84. PubMed ID: 16906226
[TBL] [Abstract][Full Text] [Related]
4. Neurofibromin is a novel regulator of RAS-induced signals in primary vascular smooth muscle cells.
Li F; Munchhof AM; White HA; Mead LE; Krier TR; Fenoglio A; Chen S; Wu X; Cai S; Yang FC; Ingram DA
Hum Mol Genet; 2006 Jun; 15(11):1921-30. PubMed ID: 16644864
[TBL] [Abstract][Full Text] [Related]
5. Cutting Edge: Codeletion of the Ras GTPase-Activating Proteins (RasGAPs) Neurofibromin 1 and p120 RasGAP in T Cells Results in the Development of T Cell Acute Lymphoblastic Leukemia.
Lubeck BA; Lapinski PE; Oliver JA; Ksionda O; Parada LF; Zhu Y; Maillard I; Chiang M; Roose J; King PD
J Immunol; 2015 Jul; 195(1):31-5. PubMed ID: 26002977
[TBL] [Abstract][Full Text] [Related]
6. The tumor suppressor neurofibromin confers sensitivity to apoptosis by Ras-dependent and Ras-independent pathways.
Shapira S; Barkan B; Friedman E; Kloog Y; Stein R
Cell Death Differ; 2007 May; 14(5):895-906. PubMed ID: 17096025
[TBL] [Abstract][Full Text] [Related]
7. The neurofibromatosis 1 gene product neurofibromin regulates pituitary adenylate cyclase-activating polypeptide-mediated signaling in astrocytes.
Dasgupta B; Dugan LL; Gutmann DH
J Neurosci; 2003 Oct; 23(26):8949-54. PubMed ID: 14523097
[TBL] [Abstract][Full Text] [Related]
8. Neurofibromin regulates neural stem cell proliferation, survival, and astroglial differentiation in vitro and in vivo.
Dasgupta B; Gutmann DH
J Neurosci; 2005 Jun; 25(23):5584-94. PubMed ID: 15944386
[TBL] [Abstract][Full Text] [Related]
9. Neurofibromatosis type I tumor suppressor neurofibromin regulates neuronal differentiation via its GTPase-activating protein function toward Ras.
Yunoue S; Tokuo H; Fukunaga K; Feng L; Ozawa T; Nishi T; Kikuchi A; Hattori S; Kuratsu J; Saya H; Araki N
J Biol Chem; 2003 Jul; 278(29):26958-69. PubMed ID: 12730209
[TBL] [Abstract][Full Text] [Related]
10. The GAP-related domain of neurofibromin attenuates proliferation and downregulates N- and K-Ras activation in Nf1-negative AML cells.
Morgan KJ; Rowley MA; Wiesner SM; Hasz DE; Van Ness B; Largaespada DA
Leuk Res; 2007 Aug; 31(8):1107-13. PubMed ID: 17222906
[TBL] [Abstract][Full Text] [Related]
11. Role of TC21/R-Ras2 in enhanced migration of neurofibromin-deficient Schwann cells.
Huang Y; Rangwala F; Fulkerson PC; Ling B; Reed E; Cox AD; Kamholz J; Ratner N
Oncogene; 2004 Jan; 23(2):368-78. PubMed ID: 14724565
[TBL] [Abstract][Full Text] [Related]
12. Crosslinking of the surface immunoglobulin receptor in B lymphocytes induces a redistribution of neurofibromin but not p120-GAP.
Boyer MJ; Gutmann DH; Collins FS; Bar-Sagi D
Oncogene; 1994 Feb; 9(2):349-57. PubMed ID: 8290249
[TBL] [Abstract][Full Text] [Related]
13. Glioma formation in neurofibromatosis 1 reflects preferential activation of K-RAS in astrocytes.
Dasgupta B; Li W; Perry A; Gutmann DH
Cancer Res; 2005 Jan; 65(1):236-45. PubMed ID: 15665300
[TBL] [Abstract][Full Text] [Related]
14. Dynamic regulation of the Ras pathway via proteolysis of the NF1 tumor suppressor.
Cichowski K; Santiago S; Jardim M; Johnson BW; Jacks T
Genes Dev; 2003 Feb; 17(4):449-54. PubMed ID: 12600938
[TBL] [Abstract][Full Text] [Related]
15. K-ras is critical for modulating multiple c-kit-mediated cellular functions in wild-type and Nf1+/- mast cells.
Khalaf WF; Yang FC; Chen S; White H; Bessler W; Ingram DA; Clapp DW
J Immunol; 2007 Feb; 178(4):2527-34. PubMed ID: 17277161
[TBL] [Abstract][Full Text] [Related]
16. Pathogenic Mutations Associated with Legius Syndrome Modify the Spred1 Surface and Are Involved in Direct Binding to the Ras Inactivator Neurofibromin.
Führer S; Tollinger M; Dunzendorfer-Matt T
J Mol Biol; 2019 Sep; 431(19):3889-3899. PubMed ID: 31401120
[TBL] [Abstract][Full Text] [Related]
17. A LAT mutation that inhibits T cell development yet induces lymphoproliferation.
Sommers CL; Park CS; Lee J; Feng C; Fuller CL; Grinberg A; Hildebrand JA; Lacaná E; Menon RK; Shores EW; Samelson LE; Love PE
Science; 2002 Jun; 296(5575):2040-3. PubMed ID: 12065840
[TBL] [Abstract][Full Text] [Related]
18. Ras-GTP regulation is not altered in cultured melanocytes with reduced levels of neurofibromin derived from patients with neurofibromatosis 1 (NF1).
Griesser J; Kaufmann D; Eisenbarth I; Bäuerle C; Krone W
Biol Chem Hoppe Seyler; 1995 Feb; 376(2):91-101. PubMed ID: 7794530
[TBL] [Abstract][Full Text] [Related]
19. Defective proliferative responses in B lymphocytes and thymocytes that lack neurofibromin.
Kim TJ; Cariappa A; Iacomini J; Tang M; Shih S; Bernards A; Jacks T; Pillai S
Mol Immunol; 2002 Feb; 38(9):701-8. PubMed ID: 11858825
[TBL] [Abstract][Full Text] [Related]
20. Retroviral integration at the Evi-2 locus in BXH-2 myeloid leukemia cell lines disrupts Nf1 expression without changes in steady-state Ras-GTP levels.
Largaespada DA; Shaughnessy JD; Jenkins NA; Copeland NG
J Virol; 1995 Aug; 69(8):5095-102. PubMed ID: 7609078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
